X
17Aug

UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?

Dechert LLP | | Return|
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By: Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/

Related

The Coronavirus and M&A Transactions: MAE Clauses

In late 2019, COVID-19 (more commonly known as the coronavirus) began to spread throughout mainland ...

Read More >

Changes to Overtime Exemptions under the Fair Labor Standards Act

In 2015, the U.S. Department of Labor introduced a proposed rule which would, in part, double the sa...

Read More >

Blood in the Water: COVID-19 M&A Implications

The COVID-19 pandemic is having a profound economic impact across the globe. Entire industries have ...

Read More >

Staying in Control: The Red Flag to Watch Out for Before Accepting Deal Risk

Whether accepting representations and warranties risk as a buyer or insurer, pay attention to the se...

Read More >

The Aftermath: Recovering From a Hurricane

It is said that preparedness is the best protection against the dangers of a hurricane. Many Easter...

Read More >

New merger control in Vietnam

On 24 March 2020, the Government of Vietnam promulgated Decree No. 35/2020/ND-CP setting forth, amon...

Read More >